Literature DB >> 11113613

Candidate genes showing no evidence for association or linkage with Alzheimer's disease using family-based methodologies.

L Bertram1, D Blacker, A Crystal, K Mullin, D Keeney, J Jones, S Basu, S Yhu, S Guénette, M McInnis, R Go, R Tanzi.   

Abstract

Alzheimer's disease (AD) is a genetically complex and heterogeneous disorder. To date, a large number of candidate genes have been associated with the disease, however none of these findings has been consistently replicated in independent datasets. In this study we report the results of family-based analyses for polymorphisms of five such candidates on chromosomes 2 (interleukin-1beta, IL-1B), 3 (butyrylcholinesterase, BCHE), 11 (cathepsin D, CTSD; Fe65, APBB1) and 12 (lipoprotein receptor-related protein-1, LRP1) that were all suggested to be associated with AD in recent case-control studies. To minimize the possibility of spurious findings due to population admixture, we used a family-based design applying the sibship disequilibrium test (SDT) as well as two-point parametric linkage analyses on families from the National Institute of Mental Health (NIMH) Genetics Initiative. Contrary to the initial reports, none of the polymorphisms that were analyzed showed evidence for association or linkage with AD in our families. Our results suggest that the previously reported associations from case-control studies are either (a) false positive results, e.g. due to type I error or population admixture, (b) smaller than initially proposed, or (c) due to linkage disequilibrium with an as yet unidentified polymorphism nearby.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11113613     DOI: 10.1016/s0531-5565(00)00193-5

Source DB:  PubMed          Journal:  Exp Gerontol        ISSN: 0531-5565            Impact factor:   4.032


  11 in total

Review 1.  The role of the cell surface LRP and soluble LRP in blood-brain barrier Abeta clearance in Alzheimer's disease.

Authors:  R Deane; A Sagare; B V Zlokovic
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 2.  Neuroinflammation in Alzheimer's disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation.

Authors:  Kenneth Hensley
Journal:  J Alzheimers Dis       Date:  2010       Impact factor: 4.472

Review 3.  Low-density lipoprotein receptor-related protein 1: a physiological Aβ homeostatic mechanism with multiple therapeutic opportunities.

Authors:  Abhay P Sagare; Rashid Deane; Berislav V Zlokovic
Journal:  Pharmacol Ther       Date:  2012-07-20       Impact factor: 12.310

Review 4.  Dancing in the dark? The status of late-onset Alzheimer's disease genetics.

Authors:  L Bertram; R E Tanzi
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

Review 5.  Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain.

Authors:  Berislav V Zlokovic; Rashid Deane; Abhay P Sagare; Robert D Bell; Ethan A Winkler
Journal:  J Neurochem       Date:  2010-10-05       Impact factor: 5.372

Review 6.  Of replications and refutations: the status of Alzheimer's disease genetic research.

Authors:  L Bertram; R E Tanzi
Journal:  Curr Neurol Neurosci Rep       Date:  2001-09       Impact factor: 5.081

7.  Cellular basis of Alzheimer's disease.

Authors:  Jitin Bali; Saoussen Ben Halima; Boas Felmy; Zoe Goodger; Sebastian Zurbriggen; Lawrence Rajendran
Journal:  Ann Indian Acad Neurol       Date:  2010-12       Impact factor: 1.383

8.  Genetic polymorphism of interleukin 1β -511C/T and susceptibility to sporadic Alzheimer's disease: a meta-analysis.

Authors:  Hai Yuan; Qing Xia; Pingping Ge; Shaowei Wu
Journal:  Mol Biol Rep       Date:  2012-10-19       Impact factor: 2.316

Review 9.  Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.

Authors:  R Deane; R D Bell; A Sagare; B V Zlokovic
Journal:  CNS Neurol Disord Drug Targets       Date:  2009-03       Impact factor: 4.388

10.  Assessment of Alzheimer's disease case-control associations using family-based methods.

Authors:  Brit-Maren M Schjeide; Matthew B McQueen; Kristina Mullin; Jason DiVito; Meghan F Hogan; Michele Parkinson; Basavaraj Hooli; Christoph Lange; Deborah Blacker; Rudolph E Tanzi; Lars Bertram
Journal:  Neurogenetics       Date:  2008-10-02       Impact factor: 2.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.